We are live on ! Find out more
IQMD

Intelligent Medicine Acquisition Corp. Class A Common Stock
IQMD

Delisted

IQMD was delisted on the 26th of April, 2023.

Back to rankings

60 hedge funds and large institutions have $197M invested in Intelligent Medicine Acquisition Corp. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

22% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 9

22% more capital invested

Capital invested by funds: $161M → $197M (+$35.7M)

3% more funds holding

Funds holding: 58 → 60 (+2)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
11
Reduced
9
Closed
7
Calls
$103K
Puts
–
Net Calls
+$103K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Calamos Advisors
Calamos Advisors
Illinois
+$12.7M
2
HIM
HGC Investment Management
Ontario, Canada
+$8.13M
3
CC
Centiva Capital
New York
+$6.3M
4
CCA
Castle Creek Arbitrage
Colorado
+$4.06M
5
KIM
Karpus Investment Management
New York
+$2.22M

Top Sellers

Rank Fund Capital Flow
1
UOC
UBS O'Connor
Illinois
-$3.85M
2
PC
Periscope Capital
Ontario, Canada
-$1.61M
3
SC
Sculptor Capital
New York
-$1.03M
4
WAM
Weiss Asset Management
Massachusetts
-$762K
5
BCM
Basso Capital Management
Connecticut
-$557K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$22.3M – – –
Calamos Advisors
2
Calamos Advisors
Illinois
$12.8M +$12.7M +1,250,000 New
HCM
3
Highbridge Capital Management
New York
$9.48M -$402K -39,600 -4%
HIM
4
HGC Investment Management
Ontario, Canada
$8.22M +$8.13M +800,000 New
D.E. Shaw & Co
5
D.E. Shaw & Co
New York
$8.09M +$10.2K +1,000 +0.1%
SC
6
Sculptor Capital
New York
$7.85M -$1.03M -100,925 -12%
HSBC Holdings
7
HSBC Holdings
United Kingdom
$7.77M +$1.03M +100,925 +15%
Millennium Management
8
Millennium Management
New York
$7.22M +$203K +20,000 +3%
CC
9
Centiva Capital
New York
$6.9M +$6.3M +620,487 +1,235%
PC
10
Periscope Capital
Ontario, Canada
$6.63M -$1.61M -158,900 -20%
Marshall Wace
11
Marshall Wace
United Kingdom
$6.38M – – –
AA
12
AQR Arbitrage
Connecticut
$5.83M +$137K +13,455 +2%
PAMP
13
Polar Asset Management Partners
Ontario, Canada
$5.56M +$1.01K +99 +0%
AC
14
Aristeia Capital
Connecticut
$5.21M +$508K +50,000 +11%
MI
15
MMCAP International
Cayman Islands
$5.14M – – –
CSS
16
Cubist Systematic Strategies
Connecticut
$4.53M -$133K -13,107 -3%
FTCM
17
First Trust Capital Management
Illinois
$4.43M – – –
SCM
18
Shaolin Capital Management
Florida
$4.32M – – –
WRBC
19
W.R. Berkley Corp
Connecticut
$4.17M – – –
CCA
20
Castle Creek Arbitrage
Colorado
$4.11M +$4.06M +400,000 New
MF
21
Magnetar Financial
Illinois
$3.52M – – –
FTCM
22
Fir Tree Capital Management
New York
$3.24M +$191K +18,811 +6%
RCM
23
Radcliffe Capital Management
Pennsylvania
$3.09M – – –
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$3.09M – – –
KL
25
KIM LLC
Kansas
$2.57M – – –
1
2 3

IQMD Hedge Fund Activity: Q4 2022 in Review

60 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) for Q4 2022, worth a combined $197M — up 22% from $161M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IQMD positions and 7 closed out — a net gain of 2 holders — while 11 added to existing stakes and 9 trimmed.

The largest buyer was Calamos Advisors, opening a new position worth an estimated $12.7M. The largest seller was UBS O'Connor, exiting entirely with an estimated $3.85M sold.

  • 60 institutional investors held Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) as of Q4 2022, up from 58 in Q3 2022.
  • Funds reported $197M of Intelligent Medicine Acquisition Corp. Class A Common Stock stock for Q4 2022, up 22% quarter-over-quarter.
  • 9 funds opened new Intelligent Medicine Acquisition Corp. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +2 holders.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock buyer in Q4 2022 was Calamos Advisors, an estimated $12.7M added.
  • The largest Intelligent Medicine Acquisition Corp. Class A Common Stock seller in Q4 2022 was UBS O'Connor, an estimated $3.85M sold.

Based on aggregated 13F filings for Q4 2022.